Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cholecystitis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    37 result(s) found for: Cholecystitis. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2021-002629-95 Sponsor Protocol Number: 170188 Start Date*: 2022-08-02
    Sponsor Name:Department of vascular surgery, Lillebaelt Hospital
    Full Title: Cefuroxime and Piperacillin Concentrations in the Biliary System
    Medical condition: Infection in the biliary system such as cholecystitis and cholangitis both as acute infections and post-operative infections.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004871 10008618 Cholecystitis chronic NOS LLT
    20.0 100000004871 10008615 Cholecystitis acute NOS LLT
    20.0 100000004871 10008619 Cholecystitis NOS LLT
    20.0 100000004871 10004638 Bile duct stone with cholecystitis LLT
    20.0 100000004871 10007004 Calculus of gallbladder with acute cholecystitis LLT
    20.0 100000004871 10006995 Calculus of bile duct with acute cholecystitis LLT
    20.0 100000004871 10008606 Cholangitis acute NOS LLT
    20.0 100000004871 10008608 Cholangitis NOS LLT
    20.0 100000004871 10008607 Cholangitis chronic NOS LLT
    20.1 100000004862 10056952 Septic cholangitis LLT
    23.0 100000004862 10083504 Acute obstructive suppurative cholangitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013470-41 Sponsor Protocol Number: PHRC N09 - Pr. REGIMBEAU Start Date*: 2009-08-19
    Sponsor Name:CHU d'Amiens
    Full Title: Place de l’antibiothérapie postopératoire dans la cholécystite aiguë lithiasique. Antibiothérapie postopératoire de courte durée versus absence d’antibiothérapie postopératoire
    Medical condition: cholécystite aiguë
    Disease: Version SOC Term Classification Code Term Level
    12.0 10000691 Acute cholecystitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002056-14 Sponsor Protocol Number: AC-DC-01 Start Date*: 2006-08-28
    Sponsor Name:Universitätsklinikum Heidelberg
    Full Title: Akute Cholezystitis – Frühe laparoskopische Operation versus antibiotischer Therapie mit elektiver Cholezystektomie im Intervall (ACDC-Studie) (Acute cholecystitis – early laparoscopic surgery vers...
    Medical condition: Akute Cholezystitis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000691 Acute cholecystitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-004878-29 Sponsor Protocol Number: NA Start Date*: Information not available in EudraCT
    Sponsor Name:St. Antonius Hospital
    Full Title: Perioperative antibiotic use in the treatment of acute calculous cholecystitis
    Medical condition: Acute calculous cholecystitis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10019805 - Hepatobiliary disorders 10008612 Cholecystitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-010265-23 Sponsor Protocol Number: EudraCTnr 2009-010265-23 Start Date*: 2010-10-03
    Sponsor Name:Gastrocentrum kirurgi
    Full Title: A prospective, randomized, blinded, placebo-controlled study of the value of preoperative treatment with Tazocin on bacterial contamination and infectious complications in patients with acute chole...
    Medical condition: Patients with cholecystitis scheduled for acute cholecystectomy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021240-18 Sponsor Protocol Number: ARHSG062010 Start Date*: 2011-04-19
    Sponsor Name:AZIENDA OSPEDALIERA S. GERARDO DI MONZA
    Full Title: Peritoneal nebulization of Ropivacaine for pain control after laparoscopic colectomy
    Medical condition: Elective Laparoscopic colectomy
    Disease: Version SOC Term Classification Code Term Level
    14.1 10019805 - Hepatobiliary disorders 10017633 Gallbladder inflammation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-005865-37 Sponsor Protocol Number: PIL-629-WEB-0128-I Start Date*: Information not available in EudraCT
    Sponsor Name:Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan
    Full Title: Levofloxacin vs Piperacillin/Sulbactam and Sultamicillin in patients with acute cholecystitis. A double blind, randomized study.
    Medical condition: acute cholecystitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-005919-24 Sponsor Protocol Number: C/399/2002 Start Date*: 2006-07-19
    Sponsor Name:Dr. Falk Pharma Portugal
    Full Title: Randomized, multicenter, double blind, placebo controlled trial, for the evaluation of the efficacy and tolerability of ursodeoxycholic acid on the dissolution of cholesterol gallstones (<15mm) aft...
    Medical condition: Randomized multicenter double blind, placebo controlled trial, for the evaluation of the efficacy and tolerability of UDCA on the dissolution of cholesterol gallstones (<15mm) after 18 months of th...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005135-15 Sponsor Protocol Number: 8101 colloidAug08 Start Date*: 2009-01-12
    Sponsor Name:University of Nottingham
    Full Title: Do 100 kiloDaltons matter? A prospective randomised double-blind study on the blood volume expanding effects of two different colloids in patients undergoing laparoscopic cholecystectomy
    Medical condition: Patients undergoing laparoscopic cholecystectomy
    Disease: Version SOC Term Classification Code Term Level
    9.1 10006990 Calculus gallbladder LLT
    9.1 10017626 Gallbladder disorder LLT
    9.1 10006992 Calculus in gallbladder LLT
    9.1 10042140 Stone in gallbladder LLT
    9.1 10029543 Non-functioning gallbladder LLT
    9.1 10003643 Atonic gallbladder LLT
    9.1 10017633 Gallbladder inflammation LLT
    9.1 10058468 Laparoscopic surgery LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-002638-35 Sponsor Protocol Number: 3.00 Start Date*: 2012-07-31
    Sponsor Name:Stockholms Läns Landsting, Karolinska Universitetssjukhuset Huddinge, Anestesikliniken
    Full Title: ALBUMIN KINETICS BY 123I-HSA A validation study on healthy volunteers, patients with acute inflammation, and patiens scheduled for major abdominal surgery
    Medical condition: A) healthy volunteers (transcapillary escape rate of albumin, plasmavolume, and turnover of albumin) B) Acute inflammation such as pancreatitis or cholecystitis C) Scheduled major abdominal surge...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-003245-29 Sponsor Protocol Number: SA652013 Start Date*: 2016-12-19
    Sponsor Name:Amsterdam AMC, locatie AMC
    Full Title: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy
    Medical condition: Prevention of symptomatic gallstone disease
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2022-000904-36 Sponsor Protocol Number: IBS-DOTIG-ECM-2202 Start Date*: 2022-05-09
    Sponsor Name:Instituto de Investigación Biomédica de Salamanca
    Full Title: Randomized clinical trial to evaluate the dose and administration time of indocyanine green in near-infrared fluorescent cholangiography during laparoscopic cholecystectomy.
    Medical condition: Laparoscopic cholecystectomy.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10008611 Cholecystectomy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: View results
    EudraCT Number: 2011-003174-89 Sponsor Protocol Number: AUDC/11 Start Date*: 2013-01-28
    Sponsor Name:Enrique De Madaria Pascual
    Full Title: Ursodeoxycholic acid in the secondary prophylaxis of acute biliary pancreatitis: pilot clinical trial randomized double-blind.
    Medical condition: Gallstone Dissolution
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004856 10050844 Pancreatitis due to gallstones LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-001416-15 Sponsor Protocol Number: 2019-ANA-01-CAZ-AVI Start Date*: 2021-03-09
    Sponsor Name:Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH
    Full Title: Pharmacokinetics of Ceftazidime-Avibactam in Bile Fluid – an in-vivo Study
    Medical condition: N/A => Pharmacokinetic study
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-001913-34 Sponsor Protocol Number: TP-434-008 Start Date*: 2013-08-16
    Sponsor Name:Tetraphase Pharmaceuticals, Inc.
    Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Ertapenem in Complicated Intra-abdominal Infections
    Medical condition: Complicated Intra-abdominal Infections
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004862 10056570 Intra-abdominal infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed) CZ (Completed) EE (Completed) LT (Completed) DE (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2016-002208-21 Sponsor Protocol Number: TP-434-025 Start Date*: 2016-09-27
    Sponsor Name:Tetraphase Pharmaceuticals, Inc.
    Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Meropenem in Complicated Intra-abdominal Infections
    Medical condition: Complicated Intra-abdominal Infections
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10056570 Intra-abdominal infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) CZ (Completed) LV (Completed) EE (Completed) LT (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2007-002121-80 Sponsor Protocol Number: 47/2007/O/Sper Start Date*: 2007-09-25
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: A prospective, double-blind, multi center, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin- Sulbactam 3 days in the treatment of localized communi...
    Medical condition: localized community acquired intra-abdominal infection (IAI)
    Disease: Version SOC Term Classification Code Term Level
    6.1 10017967 HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002119-27 Sponsor Protocol Number: CXA-cIAI-10-08 Start Date*: 2012-01-25
    Sponsor Name:Cubist Pharmaceuticals, Inc.
    Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVENOUS CXA-201 WITH THAT OF MEROPENEM IN COMPLICATED INTRAABDOMINAL INFECTIONS
    Medical condition: Complicated Intraabdominal Infections
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed) BE (Completed) LV (Completed) SK (Completed) LT (Completed) EE (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2011-002120-41 Sponsor Protocol Number: CXA-cIAI-10-09 Start Date*: 2012-02-08
    Sponsor Name:Cubist Pharmaceuticals, Inc.
    Full Title: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF INTRAVENOUS CXA-201 WITH THAT OF MEROPENEM IN COMPLICATED INTRAABDOMINAL INFECTIONS
    Medical condition: Complicated Intra abdominal Infections
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed) DE (Completed) PL (Completed) BG (Completed) LT (Completed) EE (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2006-002727-16 Sponsor Protocol Number: IP-CAT-GC-03 Start Date*: 2007-03-06
    Sponsor Name:Fresenius Biotech GmbH
    Full Title: Multicenter, open-label phase II study to evaluate the safety and efficacy of the tri-functional bispecific antibody catumaxomab (anti-EpCAM x anti-CD3) in patients with gastric adenocarcinoma afte...
    Medical condition: Gastric Neoplasm malignant
    Disease: Version SOC Term Classification Code Term Level
    15.0 10017947 - Gastrointestinal disorders 10017812 Gastric neoplasms malignant HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed) GB (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 24 06:52:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA